UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Morphological characterization of silver nanoparticles in-situ with poly (vinyl alcohol) based smart gel matrix

AIP Conference Proceedings, 2020, Vol.2224 (1)

2020

Volltextzugriff (PDF)

A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.1655-1661

2010

Volltextzugriff (PDF)

Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

Journal of clinical oncology, 2009-12, Vol.27 (35), p.6052-6069

2009

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer

Clinical lung cancer, 2017-11, Vol.18 (6), p.615-625.e8

2017

Volltextzugriff (PDF)

A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies

Clinical cancer research, 2009-09, Vol.15 (17), p.5569-5575

2009

Volltextzugriff (PDF)

Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology

The Journal of thoracic and cardiovascular surgery, 2009-10, Vol.138 (4), p.1039-1040

2009

Volltextzugriff (PDF)

Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial

The Lancet (British edition), 2022-10, Vol.400 (10358), p.1103-1116

2022

Volltextzugriff (PDF)

Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

Journal of clinical oncology, 2021-11, Vol.39 (33), p.3725-3736

2021

Volltextzugriff (PDF)

ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non–Small-Cell Lung Cancer: Expert Panel on Radiation Oncology–Lung

International journal of radiation oncology, biology, physics, 2010-11, Vol.78 (4), p.969-974

2010

Volltextzugriff (PDF)

Smoking Cessation: An Integral Part of Lung Cancer Treatment

Oncology, 2010-01, Vol.78 (5-6), p.289-301

2010

Volltextzugriff (PDF)

Extended And Expanded Roles Of Nurse In Promotive, Preventive, Curative And Restorative Health Care Delivery System In Community And Institution

Jai Maa Saraswati Gyandayini An International Multidisciplinary e-Journal, 2017-01, Vol.2 (III), p.4-6

2017

Volltextzugriff (PDF)

Update in Lung Cancer 2008

American journal of respiratory and critical care medicine, 2009-05, Vol.179 (10), p.860-868

2009

Volltextzugriff (PDF)

Abstract CT188: IMmotion151: updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT188-CT188

2021

Volltextzugriff (PDF)

13. Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) with Spinal Metastases

The spine journal, 2009, Vol.9 (10), p.6S-7S

2009

Volltextzugriff (PDF)

Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone

Clinical cancer research, 2013, Vol.19 (1), p.215-224

2013

Volltextzugriff (PDF)

Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4088-4088

2019

Volltextzugriff (PDF)

Update in Lung Cancer 2007

American journal of respiratory and critical care medicine, 2008-05, Vol.177 (9), p.941-946

2008

Volltextzugriff (PDF)

Perception of students regarding sexual harassment

International Journal Of Community Medicine And Public Health, 2021-02, Vol.8 (3), p.1257

2021

Volltextzugriff (PDF)

Phase I trial of perillyl alcohol administered four times daily continuously

Cancer chemotherapy and pharmacology, 2003-11, Vol.52 (5), p.361-366

2003

Volltextzugriff (PDF)

Optimal Adjuvant Therapy for Non‐Small Cell Lung Cancer—How to Handle Stage I Disease

The oncologist (Dayton, Ohio), 2007-03, Vol.12 (3), p.331-337

2007

Volltextzugriff (PDF)

Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study

Journal of thoracic oncology, 2009-04, Vol.4 (4), p.522-526

2009

Volltextzugriff (PDF)

Pharmacokinetics (PK) and exposure-response (ER) of rilotumumab (Rmab) in patients (pts) with small-cell lung cancer (SCLC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7593-7593

2014

Volltextzugriff (PDF)

Role of Trace Constituent in Ground Water Quality in Nine Tribal Block of Madhya Pradesh, India

International journal of current microbiology and applied sciences, 2018-01, Vol.7 (1), p.2381-2386

2018

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(71)

Publikationsform

Sprache

Englisch
(87)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(36)
Humans
(33)
Oncology
(20)
Female
(19)
Male
(18)
Middle Aged
(17)
Aged
(12)
Adult
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Lung Neoplasms - Drug Therapy
(8)
Neoplasm Staging
(8)
Respiratory System
(8)
Treatment Outcome
(8)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(7)
General & Internal Medicine
(7)
Lung Cancer
(7)
Lung Neoplasms - Pathology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study

Morphological characterization of silver nanoparticles in-situ with poly (vinyl alcohol) based smart gel matrix

A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307

Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer

A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies

Latest information for the thoracic surgeon from the Annual Meeting of the American Society of Clinical Oncology

Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial

Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non–Small-Cell Lung Cancer: Expert Panel on Radiation Oncology–Lung

Smoking Cessation: An Integral Part of Lung Cancer Treatment

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Extended And Expanded Roles Of Nurse In Promotive, Preventive, Curative And Restorative Health Care Delivery System In Community And Institution

Update in Lung Cancer 2008

Abstract CT188: IMmotion151: updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)

13. Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) with Spinal Metastases

Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone

Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial

Update in Lung Cancer 2007

Perception of students regarding sexual harassment

Phase I trial of perillyl alcohol administered four times daily continuously

Optimal Adjuvant Therapy for Non‐Small Cell Lung Cancer—How to Handle Stage I Disease

Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study

Pharmacokinetics (PK) and exposure-response (ER) of rilotumumab (Rmab) in patients (pts) with small-cell lung cancer (SCLC)

Role of Trace Constituent in Ground Water Quality in Nine Tribal Block of Madhya Pradesh, India

Suchergebnisse filtern